127 related articles for article (PubMed ID: 38072522)
1. 2-Methoxyestradiol ameliorates paraquat-induced pulmonary fibrosis by inhibiting the TGF-β1/Smad2/3 signaling pathway.
Hou L; Yang F; Zhang Y; Li Y; Yan H; Meng C; Du Y; Zhu H; Yuan D; Gao Y
Pestic Biochem Physiol; 2023 Dec; 197():105647. PubMed ID: 38072522
[TBL] [Abstract][Full Text] [Related]
2. Effects of rapamycin against paraquat-induced pulmonary fibrosis in mice.
Shao X; Li M; Luo C; Wang YY; Lu YY; Feng S; Li H; Lang XB; Wang YC; Lin C; Shen XJ; Zhou Q; Jiang H; Chen JH
J Zhejiang Univ Sci B; 2015 Jan; 16(1):52-61. PubMed ID: 25559956
[TBL] [Abstract][Full Text] [Related]
3. Paraquat induce pulmonary epithelial-mesenchymal transition through transforming growth factor-β1-dependent mechanism.
Xie L; Zhou D; Xiong J; You J; Zeng Y; Peng L
Exp Toxicol Pathol; 2016 Jan; 68(1):69-76. PubMed ID: 26603905
[TBL] [Abstract][Full Text] [Related]
4. Involvement of epithelial-to-mesenchymal transition and associated transforming growth factor-β/Smad signaling in paraquat-induced pulmonary fibrosis.
Han YY; Shen P; Chang WX
Mol Med Rep; 2015 Dec; 12(6):7979-84. PubMed ID: 26499763
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide attenuates paraquat-induced epithelial-mesenchymal transition of human alveolar epithelial cells through regulating transforming growth factor-β1/Smad2/3 signaling pathway.
Bai YW; Ye MJ; Yang DL; Yu MP; Zhou CF; Shen T
J Appl Toxicol; 2019 Mar; 39(3):432-440. PubMed ID: 30265375
[TBL] [Abstract][Full Text] [Related]
6. [Protective effect of metformin on pulmonary fibrosis caused by paraquat through activating AMP-activated protein kinase pathway].
Liu T; Gao L; Wang J; Wu L; Zhou M
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Dec; 35(12):1309-1315. PubMed ID: 38149395
[TBL] [Abstract][Full Text] [Related]
7. [The role of transforming growth factor-β
Li HH; Cai Q; Wang YP; Liu HR; Huang M
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2016 Jul; 34(7):484-488. PubMed ID: 27682480
[No Abstract] [Full Text] [Related]
8. Therapeutic potential of amitriptyline for paraquat-induced pulmonary fibrosis: Involvement of caveolin-1-mediated anti-epithelial-mesenchymal transition and inhibition of apoptosis.
Chen J; Jian X; Li C; Cheng B
Ecotoxicol Environ Saf; 2023 Apr; 254():114732. PubMed ID: 36898313
[TBL] [Abstract][Full Text] [Related]
9. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells.
Yamada A; Aki T; Unuma K; Funakoshi T; Uemura K
PLoS One; 2015; 10(3):e0120192. PubMed ID: 25799450
[TBL] [Abstract][Full Text] [Related]
10. MAPK pathway mediates epithelial-mesenchymal transition induced by paraquat in alveolar epithelial cells.
Huang M; Wang YP; Zhu LQ; Cai Q; Li HH; Yang HF
Environ Toxicol; 2016 Nov; 31(11):1407-1414. PubMed ID: 25873302
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of transforming growth factor-β type I receptor by AZ12601011 improves paraquat poisoning-induced multiple organ fibrosis.
Zhang H; Yang H; Liu XM; Ying J; Zu T; Jiang J; Liu MM; Jin J
Pestic Biochem Physiol; 2024 Mar; 200():105831. PubMed ID: 38582594
[TBL] [Abstract][Full Text] [Related]
12. Rapamycin protects against paraquat-induced pulmonary fibrosis: Activation of Nrf2 signaling pathway.
Xu Y; Tai W; Qu X; Wu W; Li Z; Deng S; Vongphouttha C; Dong Z
Biochem Biophys Res Commun; 2017 Aug; 490(2):535-540. PubMed ID: 28624451
[TBL] [Abstract][Full Text] [Related]
13. Expression and significance of HIF-1α in pulmonary fibrosis induced by paraquat.
Xie H; Tan JT; Wang RL; Meng XX; Tang X; Gao S
Exp Biol Med (Maywood); 2013 Sep; 238(9):1062-8. PubMed ID: 24048193
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of paraquat-induced pulmonary fibrosis in mice by regulating miR-140-5p expression with the fibrogenic inhibitor Xuebijing.
Dong MN; Xiao Y; Li YF; Wang DM; Qu YP; Fang TW; Li H; Liu MW
Int J Immunopathol Pharmacol; 2020; 34():2058738420923911. PubMed ID: 32462952
[TBL] [Abstract][Full Text] [Related]
15. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression.
Liu MW; Su MX; Tang DY; Hao L; Xun XH; Huang YQ
BMC Pulm Med; 2019 Feb; 19(1):35. PubMed ID: 30744607
[TBL] [Abstract][Full Text] [Related]
16. Losartan attenuates paraquat-induced pulmonary fibrosis in rats.
Guo F; Sun YB; Su L; Li S; Liu ZF; Li J; Hu XT; Li J
Hum Exp Toxicol; 2015 May; 34(5):497-505. PubMed ID: 25233898
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of SMYD2 attenuates paraquat-induced pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition through the GLIPR2/ERK/p38 axis.
Zhao Z; Yang X
Pestic Biochem Physiol; 2024 Jun; 202():105971. PubMed ID: 38879290
[TBL] [Abstract][Full Text] [Related]
18. Radix puerariae extracts ameliorate paraquat-induced pulmonary fibrosis by attenuating follistatin-like 1 and nuclear factor erythroid 2p45-related factor-2 signalling pathways through downregulation of miRNA-21 expression.
Liu MW; Liu R; Wu HY; Li YY; Su MX; Dong MN; Zhang W; Qian CY
BMC Complement Altern Med; 2016 Jan; 16():11. PubMed ID: 26758514
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
20. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
